AC Immune SA (ACIU)
NASDAQ: ACIU · Real-Time Price · USD
2.420
-0.040 (-1.63%)
Jun 2, 2026, 4:00 PM EDT - Market closed
AC Immune Market Cap
AC Immune has a market cap or net worth of $239.57 million as of June 2, 2026. Its market cap has increased by 52.01% in one year.
Market Cap
239.57M
Enterprise Value
151.69M
1-Year Change
52.01%
Ranking
Category
Stock Price
$2.42
Market Cap Chart
Since September 23, 2016, AC Immune's market cap has decreased from $867.50M to $239.57M, a decrease of -72.38%. That is a compound annual growth rate of -12.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 1, 2026 | 250.30M | -20.99% |
| Dec 31, 2025 | 316.80M | 17.51% |
| Dec 31, 2024 | 269.60M | -36.36% |
| Dec 29, 2023 | 423.60M | 145.85% |
| Dec 30, 2022 | 172.30M | -52.25% |
| Dec 31, 2021 | 360.80M | -2.88% |
| Dec 31, 2020 | 371.50M | -35.46% |
| Dec 31, 2019 | 575.60M | 6.20% |
| Dec 31, 2018 | 542.00M | -25.42% |
| Dec 29, 2017 | 726.70M | 1.07% |
| Dec 30, 2016 | 719.00M | -17.12% |
| Sep 23, 2016 | 867.50M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MacroGenics | 264.41M |
| Adagene | 262.31M |
| Context Therapeutics | 261.86M |
| Protara Therapeutics | 261.35M |
| Cellectis | 260.79M |
| Nuvectis Pharma | 258.62M |
| ALX Oncology Holdings | 255.66M |
| Entrada Therapeutics | 254.76M |